Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2024373662-A1 · Nov 7, 2024 · US
US9570688B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9570688-B2 |
| Application number | US-201514620755-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 12, 2015 |
| Priority date | Aug 5, 2010 |
| Publication date | Feb 14, 2017 |
| Grant date | Feb 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides semiconducting compounds, oligomers and polymers of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of The compounds, oligomers and polymers of formula of formula (1) are suitable for use in electronic devices such as organic field effect transistors.
Opening claim text (preview).
The invention claimed is: 1. An oligomer or polymer of formula wherein A 1 and A 2 can be the same or different and are S or Se, E is selected from the group consisting of wherein R 1 is H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 1 —R 6 , —X 2 —Ar 1 , —X 2 —Ar 2 —Ar 1 , —X 2 —Ar 2 —R 7 or —X 2 —Ar 2 —Ar 3 —R 7 , wherein X 1 at each occurrence is independently —O—, —[Z 1 —O] a —, —[O—Z 1 ] a —O—, —S—, —[Z 1 —S—] a —, [S—Z 1 ] a —S—, —S(O), —C(O)—, —C(O)O—, —C(O)NR 8 —, C(O)S—, —O(CO)—, —S(CO)—, —NR 8 C(O)— or —NR 8 —, wherein Z 1 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, a at each occurrence is independently an integer from 1 to 10 and R 8 at each occurrence is independently H, C 1-20 -alkyl, or —Z 2 —C 6-14 -aryl, wherein Z 2 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, R 6 at each occurrence is independently C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl, X 2 at each occurrence is independently —Z 3 —O—Z 4 —, —Z 3 —S—Z 4 —, —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 9 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 9 C(O)—, —NR 9 —, —Z 3 —SiR 9 2 —Z 4 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 3 and Z 4 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 9 at each occurrence is independently H, C 1-20 -alkyl, or —Z 5 —C 6-14 -aryl, wherein Z 5 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 1 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R a , wherein each R a is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 2 and Ar 3 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R b , wherein each R b is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, and R 7 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -halaolkyl, C 1-20 -alkoxy, —X 3 —Ar 4 , —X 3 —Ar 5 —Ar 4 , —X 3 —Ar 5 —R 10 , or —X 3 —Ar 5 —Ar 6 —R 10 , wherein X 3 at each occurrence is independently —Z 6 —O—Z 7 —, —Z 6 —S—Z 7 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 11 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 11 C(O)—, —NR 11 , —Z 6 —SiR 11 2 —Z 7 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 6 and Z 7 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 11 at each occurrence is independently H, C 1-20 -alkyl or —Z 8 —C 6-14 -aryl, wherein Z 8 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 4 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R c , wherein each R c is independently selected from the group consisting of halogen, CN, —C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 5 and Ar 6 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R d , wherein each R d is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, and R 10 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl or C 1-20 -alkoxy, R 3 , R 4 and R 5 can be the same or different and are H, halogen, —CN, C 1-30 -alkyl, C 2-30 -alkenyl, C 2-20 -alkynyl, C 3-10 -cycloalkyl, C 5-10 -cycloalkenyl, C 8-10 -cycloalkynyl, C 1-30 -haloalkyl, monovalent 3 to 12 membered aliphatic heterocyclic residue, —X 4 —R 12 , —X 5 —Ar 7 , —X 5 —Ar 8 —Ar 7 , —X 5 —Ar 8 —R 13 or —X 5 —Ar 8 —Ar 9 —R 13 , wherein X 4 at each occurrence is independently —[Z 9 —O] b —, —[Z 9 —S—] b —, —S(O)—, —C(O)—, —C(O)O—, —C(O)NR 14 — or C(O)S—, wherein Z 9 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, b at each occurrence is independently an integer from 1 to 10 and R 14 at each occurrence is independently H, C 1-20 -alkyl, or —Z 10 —C 6-14 -aryl, wherein Z 10 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, R 12 at each occurrence is independently C 1-30 -alkyl, C 2-30 -alkenyl or C 1-30 -haloalkyl, X 5 at each occurrence is independently —Z 11 —O—Z 12 , —Z 11 —S—Z 12 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 15 , —C(O)S—, —Z 11 —SiR 15 2 —Z 12 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 11 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene or C 1-6 -haloalkylene, Z 12 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 15 at each occurrence is independently H, C 1-20 -alkyl, or —Z 13 —C 6-14 -aryl, wherein Z 13 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 haloalkylene or a covalent bond, Ar 7 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 5 substituents R e , wherein each R e is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl, Ar 8 and Ar 9 at each occurrence are independently C 6-14 -arylene or bivalent 5 to 14 membered aromatic heterocyclic residue, each optionally substituted with 1 to 4 substituents R f , wherein each R f is independently selected from the group consisting of halogen, CN, C 1-6 -alkyl, C 1-6 -alkoxy and C 1-6 -haloalkyl and R 13 at each occurrence is independently C 1-20 -alkyl, C 2-20 -alkenyl, C 1-20 -haloalkyl, C 1-20 -alkoxy, —X 6 —Ar 10 , —X 6 —Ar 11 —Ar 10 , —X 6 —Ar 11 —R 16 , or —X 6 —Ar 11 —Ar 12 —R 17 , wherein X 6 at each occurance is independently —Z 14 —O—Z 15 —, —Z 14 —S—Z 15 , —S(O)—, —C(O)—, —C(O)O—, —(CO)NR 18 , —C(O)S—, —O(CO)—, —S(CO)—, —NR 18 C(O)—, —NR 18 —, —Z 14 —SiR 18 2 —Z 15 —, C 1-30 -alkylene, C 2-30 -alkenylene, C 1-30 -haloalkylene or a covalent bond, wherein Z 14 and Z 15 at each occurrence are independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, and R 18 at each occurrence is independently H, C 1-20 -alkyl or —Z 16 —C 6-14 -aryl, wherein Z 16 at each occurrence is independently C 1-6 -alkylene, C 2-6 -alkenylene, C 1-6 -haloalkylene or a covalent bond, Ar 10 at each occurrence is independently C 6-14 -aryl or monovalent 5 to 14 membered aromatic heterocyclic res
Field-effect transistors, e.g. organic thin-film transistors [OTFT] (H10K10/43 takes precedence) · CPC title
comprising only sulfur as heteroatom · CPC title
Polycyclic condensed heteroaromatic hydrocarbons · CPC title
Ortho-condensed systems · CPC title
Stille reactions · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.